Simon Byrns

Features, Evaluation and Treatment Coronavirus (COVID-19)

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

Mechanisms of SARS-CoV-2 entry into cells

ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – Role of gut microbiota dysbiosis

Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects

Key role of the REC lobe during CRISPR–Cas9 activation by ‘sensing’, ‘regulating’, and ‘locking’ the catalytic HNH domain

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

OpenMM 7: Rapid development of high performance algorithms for molecular dynamics

Microbiota Modulation of the Gut-Lung Axis in COVID-19

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

Pathological Role of Angiotensin II in Severe COVID-19

Enhanced Sampling in Molecular Dynamics Using Metadynamics, Replica-Exchange, and Temperature-Acceleration

Angiotensin-Converting Enzyme 2: The First Decade

COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19

Resveratrol Treatment of Mice With Pressure-Overload–Induced Heart Failure Improves Diastolic Function and Cardiac Energy Metabolism

Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction

Conformational Analysis of Oligoarabinofuranosides: Overcoming Torsional Barriers with Umbrella Sampling